Your browser doesn't support javascript.
loading
Characterization of DNA damage response deficiency in pancreatic cancer patients from China.
Zhang, Xiaofei; Mao, Tiebo; Zhang, Bei; Xu, Haiyan; Cui, Jiujie; Jiao, Feng; Chen, Dongqin; Wang, Yu; Hu, Jiong; Xia, Qing; Li, Shumin; Yue, Ming; Ma, Jingyu; Yao, Jiayu; Wang, Yongchao; Zhang, Xiao; Chen, Shiqing; Bai, Yuezong; Wang, Yuexiang; Zhang, Xuebin; Liu, Qiang; Sun, Yongwei; Fu, Deliang; Liu, Yingbin; Xiong, Lei; Wang, Liwei.
Afiliación
  • Zhang X; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Mao T; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Zhang B; The Medical Department, 3D Medicines Inc., Shanghai, 201321, P. R. China.
  • Xu H; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Cui J; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Jiao F; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Chen D; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Wang Y; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Hu J; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Xia Q; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Li S; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Yue M; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Ma J; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Yao J; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Wang Y; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Zhang X; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Chen S; The Medical Department, 3D Medicines Inc., Shanghai, 201321, P. R. China.
  • Bai Y; The Medical Department, 3D Medicines Inc., Shanghai, 201321, P. R. China.
  • Wang Y; Head of Laboratory of Cancer Progression and Translational Medicine Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
  • Zhang X; Department of Interventional Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Liu Q; Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Sun Y; Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Fu D; Department of Pancreatic Surgery, Huashan Hospital, Pancreatic Disease Institute, Shanghai Medical College, Fudan University, Shanghai, 200040, P. R. China.
  • Liu Y; Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
  • Xiong L; The Medical Department, 3D Medicines Inc., Shanghai, 201321, P. R. China.
  • Wang L; State Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, P. R. China.
Cancer Commun (Lond) ; 42(1): 70-74, 2022 01.
Article en En | MEDLINE | ID: mdl-34821074
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas País/Región como asunto: Asia Idioma: En Revista: Cancer Commun (Lond) Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas País/Región como asunto: Asia Idioma: En Revista: Cancer Commun (Lond) Año: 2022 Tipo del documento: Article